Archive - BioBoyScout

ARO-MAPT: The Setup

Why the 2026 Phase 1/2a Readout Is Built to Succeed

May 3 • BioBoyScout

The Endgame

If ARO-MAPT Works, What Is Arrowhead Worth, and When?

May 3 • BioBoyScout

Arrowhead 2026 Catalyst Calendar

Upcoming readouts through early 2027 — what to expect and what each outcome means for the thesis | Data cutoff: April 24, 2026

May 3 • BioBoyScout

The Year of Tau

ARO-MAPT, the CNS Delivery Breakthrough, and Why 2H 2026 Could Redefine Arrowhead Pharmaceuticals

May 3 • BioBoyScout

Redemplo vs. Tryngolza

Why the Price War Doesn’t Change the Outcome

May 2 • BioBoyScout

The Needle Wins

How the auto-injector revolution is ending the reign of the daily pill

May 1 • BioBoyScout

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts